Merck shares ease; EMA CHMP backs Keytruda+Padcev for MIBC
Merck & Co. shares slipped after regulatory news. Keytruda contributed $8.37B of $16.61B in quarterly revenue, and the EMA CHMP backed KEYTRUDA+Padcev for perioperative MIBC.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.